Recla, Elmera G.
HRN: 22-55-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
CEFUROXIME 750MG (VIAL)
01/30/2023
02/06/2023
IV
300mg
Q8
BFS; URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTICentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes